Abg Innovation Capital Partners Iii Gp LTD Synlogic, Inc. Transaction History

Abg Innovation Capital Partners Iii Gp LTD

  • $837,000
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.25 - $3.16 $48,044 - $607,285
-192,179 Reduced 93.33%
13,727 $38,000
Q4 2020

Feb 16, 2021
BUY
$1.85 - $2.54 $380,926 - $523,001
205,906 New
205,906 $445,000

Others Institutions Holding SYBX

# of Institutions
2
Shares Held
25.5K
Call Options Held
0
Put Options Held
0
View Full List

About SYNLOGIC, INC.

SYBX Quotes by TradingView
  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Abg Innovation Capital Partners Iii Gp LTD Portfolio

Follow Abg Innovation Capital Partners Iii Gp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abg Innovation Capital Partners Iii Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Abg Innovation Capital Partners Iii Gp LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email